跳至主要内容
临床试验/IRCT20100408003664N23
IRCT20100408003664N23已完成2 期

Effect of genistein supplementation on serum level of homocystein and PAI-1 (Plasminogen Activator Inhibitor-1) in postmenopausal women with type-2 diabetes mellitus.

utritional Reseach Center of Tabriz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 67 years(—)
性别
Female

入选标准

  • Willingness to participate in the study
  • Postmenopausal women with history of at least one year menopause
  • Type-2 diabetes for at least 6 months
  • using blood glucose lowering drugs (metformin)

排除标准

  • Unwillingness to participate in the study
  • Surgery leads to menopause
  • Early menopause (before 40 years)
  • Use of androgen and estrogen and other steroids can affect the estrogen receptor
  • Insulin injections
  • Use of any nutritional supplements (omega-3) or anti-inflammatory and antioxidant supplements in the last 3 months or during the study
  • Liver and kidney failure, cardiovascular disease, breast cancer and thyroid disease
  • Smoking and alcohol
  • Patients taking NSAID, corticosteroids (prednisone, methylprednisolone, and hydrocortisone), antidiuretic thiazide (furosemide and hydrochlorothiazide) and anti psychotics second generation (olanzapine, clozapine)

研究者

发起方
utritional Reseach Center of Tabriz University of Medical Sciences

相似试验